 Antony Waste Handling Cell Ltd Q2 FY2026 consolidated net profit down QoQ to Rs. 13.65 crores
Antony Waste Handling Cell Ltd Q2 FY2026 consolidated net profit down QoQ to Rs. 13.65 crores Eiko Lifesciences Ltd Q2FY26 consolidated PAT increases to Rs. 1.07 crore
Eiko Lifesciences Ltd Q2FY26 consolidated PAT increases to Rs. 1.07 crore LG Balakrishnan and Bros Ltd Q2 FY2026 consolidated net profit soars to Rs. 93.62 crores
LG Balakrishnan and Bros Ltd Q2 FY2026 consolidated net profit soars to Rs. 93.62 crores Mahindra Holidays and Resorts India Ltd posts higher consolidated PAT of Rs. 17.85 crores in Q2FY26
Mahindra Holidays and Resorts India Ltd posts higher consolidated PAT of Rs. 17.85 crores in Q2FY26 Balkrishna Industries Ltd consolidated Q2FY26 PAT falls to Rs. 273.19 crores
Balkrishna Industries Ltd consolidated Q2FY26 PAT falls to Rs. 273.19 crores 
              The Initial Public Offering of Ammana Bio Pharma Limited will open for subscription on Wednesday - March 28, 2007. The company is coming out with an IPO of 15,185,855 Equity shares of face value Rs.10 each at a price band of Rs.12 to Rs.14 aggregating Rs.2166.02 Lacs, including promoters contribution aggregating Rs.150.02 Lacs.
The Net issue to the public would aggregate to Rs.2016 Lacs. The issue is through 100% Book Building Process.
Out of the issue, 7,592,928 equity shares are reserved for Qualified Institutional Buyers (QIBs), 2,277,878 shares are reserved for Non Institutional Investors and 5,315,049 shares for Retail Individual Investors (RIIs).
The Equity Shares issued through this IPO are proposed to be listed on the Bombay Stock Exchange Limited ("BSE") (also the Designated Stock Exchange) and the National Stock Exchange of India Limited ("NSE").
The Book Running Lead Managers to the issue is CENTRUM Capital Ltd.
Bigshare Services Pvt Ltd is the Registrar to the issue.
The company's website is Ammana Bio Pharma Limited
Click on this link to access the Prospectus of Ammana Bio Pharma Limited